The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
Abstract
Long-term treatment with glucocorticoids (GCs) leads to a rapid bone loss and to a greater risk of fractures. To evaluate the specific effects of this treatment on cancellous bone remodeling, structure, and microarchitecture, we compared 22 transiliac biopsy specimens taken in postmenopausal women (65 ± 6 years) receiving GCs (≥7.5 mg/day, for at least 6 months) and 22 biopsy specimens taken in age-matched women with postmenopausal osteoporosis (PMOP), all untreated and having either at least one vertebral fracture or a T score < −2.5 SD. On these biopsy specimens, we measured static and dynamic parameters reflecting trabecular bone formation and resorption. Also, we performed the strut analysis and evaluated the trabecular bone pattern factor (TBPf), Euler number/tissue volume (E/TV), interconnectivity index (ICI), and marrow star volume (MaSV). Glucocorticoid-induced osteoporosis (GIOP), when compared with PMOP, was characterized by lower bone volume (BV/TV), trabecular thickness (Tb.Th), wall thickness (W.Th), osteoid thickness (O.Th), bone formation rate/bone surface (BFR/BS), adjusted mineral apposition rate/bone surface (Aj.AR/BS), and higher ICI and resorption parameters. After adjustment for BV/TV, the W.Th remained significantly lower in GIOP (p < 0.0001). The active formation period [FP(a+)] was not different. Patients with GIOP were divided into two groups: high cumulative dose GCs (HGCs; 23.7 ± 9.7 g) and low cumulative dose GCs (LGCs; 2.7 ± 1.2 g). HGC when compared with LGC was characterized by lower W.Th (p < 0.05), BV/TV (p < 0.001), Tb.Th (p < 0.05), trabecular number (Tb.N; p < 0.05), FP(a+) (p < 0.05), and nodes (p < 0.05), and higher E/TV (p < 0.05), ICI (p < 0.005), and TBPf (p < 0.05). When HGC was compared with PMOP, the results were similar except for the MaSV, which was significantly higher (p < 0.005). In summary, GIOP was characterized by lower formation and higher resorption than in PMOP, already present after LGC. With HGCs, these changes were associated with a more dramatic bone loss caused by a major loss of trabecular connectivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the skeletal response to prednisolone in these rats shared several similarities to changes observed in humans, including significantly decreased BMD (243), histological evidence of increased bone resorption (194), and biochemical evidence of suppressed bone formation (244, 267, 268).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [194]
In the citing paper
“The prednisolonerelated increase in bone volume in rats, confirmed in a study described immediately below (262), is not consistent with histological data from patients with glucocorticoid-induced osteoporosis (194) and is a recognized limitation of the model (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [194]
Citations
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationPARFITT, A. M., Mathews, C. H. E., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,542
The direct examination of three-dimensional bone architecture in vitro by computed tomography
Feldkamp, L. A., Goldstein, S. A., Parfitt, M. A., Jesion, G., & Kleerekoper, M. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040103 · Cited by 1,073
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,063
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
Adinoff, A., & Hollister, J. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090502 · Cited by 662
Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitecture
Hahn, M. P., Vogel, M., Pompesius-Kempa, M., & Delling, G. (1992) · Bone · doi:10.1016/8756-3282(92)90078-b · Cited by 540
Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis
Laan, R., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., Hof, M. A. V., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 410
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390
New Developments in the Pathogenesis and Treatment of Steroid-Induced Osteoporosis
Manolagas, S. C., & Weinstein, R. S. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1061 · Cited by 382
Research works printed but not linked: 2
- Le, 1992, Computerized quantitative analysis of the interconnectivity of porous biomaterials, Acta Stereol, 11, 267
- Gallagher, 1996, Osteoporosis, 1191
Cited by
Sorted by citations
Items 301–308 of 308
Pinto, C. M., Etchegaray‐Morales, I., Munguía‐Realpozo, P., Osorio-Peña, Á. D., Méndez‐Martínez, S., Ramírez‐Lara, E., Zárate-Arellano, D., Solís-Poblano, J. C., Ayón-Aguilar, J., & García‐Carrasco, M. (2023) · Lupus · doi:10.1177/09612033231202878
Adrenal Insufficiency: Diagnostic Approaches, Treatments, and Outcomes Volume II
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7003-6
Elmorsy, E. M., Ghafari, A. B. A., Doghaither, H. A. A., Alrowaili, M. G., Khired, Z. A., Fawzy, M. S., & Shehata, S. A. (2025) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.20261072
Payer, J., Tomková, S., Killinger, Z., Brázdilová, K., Jackuliak, P., Vaňuga, P., Letkovská, A., Masaryk, P., Kmečová, Z., & Kužma, M. (2018) · Clinical Osteology · doi:10.36290/clo.2018.019
The Assessment and Management of Osteoporosis in Childhood
Burnham, J. M., & Ward, L. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11980-4.00015-5
Confavreux, C. B., Bouvard, B., Blank, R., Hadji, P., Biver, E., Body, J., Brandi, M. L., Campusano, C., Ebeling, P. R., Maghraoui, A. E., et al. (2026) · Osteoporosis International · doi:10.1007/s00198-026-08178-0
Sihota, P., Junimann, X., Krug, J., Frischmuth, J., Harms, L., Yorgan, T. A., Fiedler, I. A. K., Veldhuis‐Vlug, A. G., Jobke, B., Amling, M., et al. (2026) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjag140
Characterisation of 11beta hydroxysteroid dehydrogenase 1 in ocular and orbital tissues
Onyimba, C. (2010) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Metadata
- Authors
- Carbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J.
- Affiliations
- Inserm (FR)
- Institut National de la Santé et de la Recherche Médicale Unit 403 and Laboratoire d'Histodynamique Osseuse, Lyon, France
- Corresponding author
- Carbonare, L. Dalle
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 97-103
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1972567404
- Cited by
- 309
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 14 · 2017: 7 · 2016: 5 · 2015: 12 · 2014: 12 · 2013: 12 · 2012: 16
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoid-induced osteoporosis, postmenopausal osteoporosis, trabecular bone microarchitecture, bone remodeling, trabecular bone, bone formation rate, bone resorption, cumulative glucocorticoid dose, bone loss, trabecular thickness, wall thickness, Euler characteristic
- MeSH terms
- Aged, Biopsy, Bone and Bones, Female, Glucocorticoids, Histocytochemistry, Humans, Ilium, Middle Aged, Osteoporosis, Osteoporosis, Postmenopausal, Bone Remodeling, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
